It is estimated that up to half of the UK population will be affected by cancer during their
lifetime (1, 2). Whilst half of all people diagnosed with cancer will survive their disease for …

In this issue of The Journal of Nuclear Medicine, Thornton et al. present 18F-FDG PET/CT
data obtained on coronavirus disease 2019 (COVID-19) patients at several disease stages …

The aim of this study was to assess the temporal evolution of pulmonary 18F-FDG uptake in
patients with coronavirus disease 2019 (COVID-19) and post–COVID-19 lung disease …

To date, the whole population is at risk of infection with the coronavirus COVID-19 (SARS-
CoV-2); in particular, older people, often frail and subject to multimorbidity, are at highest risk …

SARS-CoV-2 virus infects organs other than the lung, such as mediastinal lymph nodes,
spleen, and liver, but, to date, metabolic imaging studies obtained in short-term follow-ups of …

consultation. CT is a sensitive test to detect lung cancer but not specific, especially if staging
information is required. 7e10 Similarly, the added information provided by FDG-PET …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in an ongoing global pandemic of coronavirus disease 2019 (COVID-19). The …

Inflammatory and infectious pulmonary diseases represent a significant cause of morbidity
and mortality. Different morphological imaging techniques, and mainly computed …

2012 Objectives: Review the present use of 18F-FDG-PET in lung inflammation/interstitial
lung diseases. Review the potential value of 18F-FDG-PET in the global measurement and …

While not conventionally used as the first-line modality,[18 F]-2-fluoro-2-deoxy-D-glucose
(FDG)-positron emission tomography/computed tomography (PET/CT) can identify infection …